$VNDA

$3.94 -$0.07 (1.75%) Close

$VNDA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 60.5M shares outstanding

Who owns VNDA?

By type of holder

Institutions 81.7% Insiders 9.0% Everyone else 9.3%

Concentration Top 10 holders own 50.7%

BlackRock, Inc. 12.7% · Renaissance Technologies LLC 5.7%

Institutional ownership

81.7%

+5.2 pts vs last qtr

Institutional holders

170

-1 vs last qtr

Net shares bought

+3.1M

by institutions in Q2 2026

New / sold out

28 / 29

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Aqr Capital Management LLC +1.9M
Qube Research & Technologies Ltd NEW +729.2K

Biggest sellers in Q2 2026

Empire Financial Management Company, LLC SOLD OUT −922.2K
AIGH Capital Management LLC −705.8K

Who is planning to sell?

Notices of proposed sale, last 12 months

$2.82M

6 notices from 6 people

Shares covered

344.3K

0.57% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Mihael H. Polymeropoulos Officer $1.28M
Kevin Moran Svp, cfo & treasurer $351K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+35.6%

+3.44% a year

Each share's claim on the business

−26.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $125M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years66% 3–5 years4% 1–3 years13% Under 1 year18%

Quarterly turnover

13.6%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting VNDA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	7.7M	12.66%	+377.7K (+5.2%)	≤2021	0.0%
Shares held by quarter Peak holding9.4M (Q2'25) Change over 8 quarters−941.9K Share of the company12.660% BlackRock, Inc.'s full portfolio →
RT Renaissance Technologies LLC	3.4M	5.69%	−318.2K (−8.5%)	≤2021	0.0%
Shares held by quarter Peak holding4.0M (Q3'24) Change over 8 quarters−570.2K Share of the company5.690% Renaissance Technologies LLC's full portfolio →

BlackRock, Inc.

7.7M

% of company

12.66%

Change vs last qtr

+377.7K (+5.2%)

Held since

≤2021

Renaissance Technologies LLC

3.4M

% of company

5.69%

Change vs last qtr

−318.2K (−8.5%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Vanda Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting VNDA on Form N-PORT; together they hold 28.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SS State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR Series Trust	$14M	2.3M	3.79%	0.13%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$10.8M	1.8M	2.91%	0.00%	June 30, 2026

State Street(R) SPDR(R) S&P(R) Biotech ETF

SPDR Series Trust

Position value

$14M

% of company

3.79%

% of the fund

0.13%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$10.8M

% of company

2.91%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Vanda Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PM Polymeropoulos Mihael Hristos Insider	2.7M	4.47%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company4.470% Polymeropoulos Mihael Hristos's insider activity →
BG Birznieks Gunther Insider	494.2K	0.82%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.820% Birznieks Gunther's insider activity →

Polymeropoulos Mihael Hristos

Insider

2.7M

% of company

4.47%

Change vs last qtr

—

Held since

—

Birznieks Gunther

Insider

494.2K

% of company

0.82%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of Vanda Pharmaceuticals Inc.

Comments